Medicaments containing xenogeneic oligo- and/or polyribonucleotides
OwnerHugo Seinfeldinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to medicaments that contain xenogenic oligo- or/and polyribonucleotides as the effective component. The invention further relates to the use of said xenogenic oligo- or/and polyribonucleotides for treating herpesviridae infections and skin tumors.
Claims59
1-14. (canceled)
A method for the treatment of Herpesviridae infections by and/or skin tumors in a subject comprising administering to the subject in need thereof an amount of at least 0.1 mg of xenogeneic oligo- and/or polyribonucleotides once per recurrence of symptoms.
A method for treating lesions of the skin and/or mucosa caused by Herpes simplex virus and/or Varicella zoster virus comprising administering a therapeutically effective amount of a pharmaceutical composition comprising xenogenic oligo- and/or polyribonucleotides to a subject in need thereof once per recurrence of symptoms.
A method for the treatment of infections by Herpesviridae and/or skin tumors, comprising administering an active amount of at least 0.1 mg of xenogeneic oligo- and/or polyribonucleotides in an anhydrous preparation once per recurrence of symptoms to a subject in need thereof.
A method for the treatment of infections by at least one of Herpesviridae or skin tumors comprising administering to a subject in need thereof a therapeutically effective amount of xenophobic oligo- and/or polyribonucleotides once per recurrence of symptoms.
A method for the treatment of a subject having a Herpesviridae infection and/or a skin tumor comprising administering to the subject an amount of xenogeneic RNA obtained by homogenizing cells containing RNA in a sucrose-containing buffer.
A method for treating lesions of the skin and/or mucosa caused by Herpes simplex virus and/or Varicella zoster virus comprising administering a therapeutically effective amount of a pharmaceutical composition comprising xenogenic RNA obtained by homogenizing cells containing RNA in a sucrose-containing buffer.
A method for the treatment of infections by Herpesviridae and/or skin tumors comprising administering a therapeutically effective amount of xenogeneic RNA obtained by homogenizing cells containing RNA in a sucrose-containing buffer.
A method for preventing a recurrence of a herpes virus infection comprising administering a single application of a therapeutically effective amount of anhydrous preparation of xenogeneic RNA prepared by extracting cells containing the RNA with phenol in the presence of sucrose to the affected area of a subject in need thereof.
Dependencies are inferred from the claim text.